Publication | Closed Access
Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats
70
Citations
19
References
2009
Year
Metabolic SyndromeDiabetes ManagementSelective Sglt2 InhibitorBiochemistryMedicinePhysiologyDiabetesSergliflozin EtabonateDiabetes MellitusPharmacologyStreptozotocin-induced Diabetic RatsHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1